All lobbying filings

DLA PIPER LLP (US)

DLA PIPER LLP (US) filed a Q3 report for PRELUDE CORPORATION (PRELUDEDX) on October 19, 2026, reporting $70,000 in lobbying income.

Lobbying for PRELUDE CORPORATION (PRELUDEDX) · Precision cancer diagnostics company.

All filings by DLA PIPER LLP (US) · Everything PRELUDE CORPORATION (PRELUDEDX) has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 19, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Improved patient access to cancer screening diagnostics.

Medicare/Medicaid

Policies related to Medicare reimbursement for cancer diagnostics.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.